Occam Strengthens its Partnership with EveryONE Medicines with Placement of Chief Medical Officer
In April 2025, Occam Global, a leader in executive recruiting for the life sciences, placed Michelle Mellion, MD, as CMO of EveryONE Medicines, a company pioneering personalized genetic medicines for children with life-threatening neurodegenerative diseases.
Michelle brings extensive experience in evaluating and treating neurological diseases, having worked in both academic and clinical development settings. Most recently, she was the CMO at PepGen. Prior to joining PepGen, she held roles of increasing responsibility at Fulcrum Therapeutics, Vertex Pharmaceuticals, and Biogen.
Michelle completed her residency at Brown Medical School, received her M.D. from Wake Forest University School of Medicine, and earned her B.A. in Molecular Biology from Colgate University.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.